The FDA approved Epioxa for the treatment of keratoconus, Glaukos announced in a press release.
“We’re proud to announce an extraordinary milestone for keratoconus patients with the approval of Epioxa,” Thomas Burns, Glaukos chairman and CEO, told Healio. “Epioxa is the result of years of dedicated innovation, research and determination to set a new standard in keratoconus care. As the first and only FDA-approved incision-free procedure using bioactive topical drops for keratoconus, this approval underscores our unwavering commitment to addressing critical unmet needs in ophthalmology.”
The